Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases.

ABSTRACT: Aptamers are oligonucleotides selected from large pools of random sequences based on their affinity for bioactive molecules and are used in similar ways to antibodies. Aptamers provide several advantages over antibodies, including their small size, facile, large-scale chemical synthesis, high stability, and low immunogenicity. Amyloidogenic proteins, whose aggregation is relevant to neurodegenerative diseases, such as Alzheimer's, Parkinson's, and prion diseases, are among the most challenging targets for aptamer development due to their conformational instability and heterogeneity, the same characteristics that make drug development against amyloidogenic proteins difficult. Recently, chemical tethering of aptagens (equivalent to antigens) and advances in high-throughput sequencing-based a

SUBMITTER: Murakami K 

PROVIDER: S-EPMC8728582 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature